Top Story

New model predicts HCV progression, liver-related events

New model predicts HCV progression, liver-related events
May 22, 2015

A risk prediction model developed by researchers from University of Michigan Health System, helped identify which patients with hepatitis C virus infection have the most urgent need for new anti-viral treatment, according to newly published data in Hepatology.

“Offering immediate treatment to patients identified as high risk for poor health outcomes would allow these patients to benefit from highly effective treatments as other patients continue to be monitored and their risk assessment updated at each clinic visit,” Monica Konerman, MD, MSc, gastroenterology fellow at the University of Michigan Health System, said in a press release.

Foundation aims to assist HCV patients with therapy costs

May 22, 2015
The HealthWell Foundation announced the launch of a new fund aimed to assist people living with hepatitis C virus infection who are underinsured, according to a news…
EditorialPublication Exclusive

Screening Toward a 'Cure'

Healio Gastroenterology, May 2015
As rates of resolved hepatitis C virus continue to rise with the addition of newer, stronger medications, our experts debate the overall screening strategies put forth…
Healio Gastroenterology May 2015 Cover StoryPublication Exclusive

Weighing the Wisdom of Expanded HCV Screening

Healio Gastroenterology, May 2015
Many organizations, including the CDC, have endorsed expanding widespread screening for hepatitis C virus, but experts writing in The BMJ warn that physicians should…

Exviera, Viekirax combination added benefit for patients with HCV without cirrhosis

May 21, 2015
In a manufacturer dossier assessment conducted by the Institute for Quality and Efficiency in Health Care in Germany, Exviera when used in combination with Viekirax was…
More News Headlines »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video

VIDEO: NAFLD patients need a healthy lifestyle

May 13, 2015
VIENNA — In a video perspective from the 2015 International Liver Congress, Howard Monsour Jr., MD, chief of…
More »
CME
HCV Consults: Volume 1, Number 3

HCV Consults: Volume 1, Number 3

This activity is supported by educational grants from AbbVie and Genentech, Inc.

More »